fbpx

Our Favorite Photos of 2023

From hospital expansions and cholera treatment to lifesaving medical oxygen and global advocacy, images tell PIH’s story  Posted on Dec 23, 2023 Partners In Health staff and partners expanded a state-of-the-art hospital in Rwanda. Clinicians cured patients living with tuberculosis. Technicians helped deliver lifesaving oxygen to more patients across the Read more…

Multidrug-Resistant Tuberculosis: Improving the Standard of Care in Sierra Leone

Saio Kamara proudly holds a yellow, pocket-sized paper and with a smile tells those around her: “This is my TB certificate.”  

It’s more than just a piece of paper. It marks a major milestone: being cured of multidrug-resistant tuberculosis (MDR-TB). The document includes details, such as her diagnosis, treatment type, and, most importantly, her completion date: March 31, 2022. It’s a day she’ll never forget.

Toronto Star : Something is sustainable only when we decide to sustain it

Sustainability requirements for charitable organizations or local partners are more about funders’ unspoken needs for an exit strategy than a measure of smart project design. Toronto Star Op-Ed written by Mark Brender Originally published on the Toronto Star. Donors to international development initiatives often cite project sustainability as a key criterion in their Read more…

Landmark Clinical Trial Redefines Multidrug-Resistant Tuberculosis Treatment Options

Clinical trial results presented for the first time today at the Union World Conference on Lung Health revealed evidence to support the use of four new, improved regimens to treat multi-drug resistant tuberculosis or rifampicin-resistant tuberculosis (MDR/RR-TB). The team—led by Médecins Sans Frontières (MSF), Partners In Health (PIH), and Interactive Research and Development (IRD) and funded by Unitaid—formed the endTB consortium and began this Phase III randomized controlled trial in 2017. 

SUBSCRIBE